Under det kliniske udviklingsprogram forud for godkendelse blev et samlet antal på 1737 graviditeter rapporteret, heriblandt 870 kvinder, som havde modtaget Cervarix.
During the pre-licensure clinical development program, a total of 1,737 pregnancies were reported including 870 in women who had received Cervarix.